Hemo Alliance Newsletters

Legal Update, July 2021

Legal Update

Compliance Program Check-Up: OIG’s Seven Elements of Compliance
by Elizabeth “Issie” Karan

For decades, the Office of the Inspector General (OIG) for the Department of Health and Human Services (HHS) has provided its perspective on the most important elements to consider when developing and implementing an effective compliance program. Hospitals are required to implement these elements, but any health care entity can benefit from considering them as they update and augment their programs. Please keep in mind that these elements apply to general compliance programs. While they may be useful in ensuring 340B Program compliance, they are intended to apply broadly to all potential areas of risk for health care organizations (e.g., billing, fraud, financial relationships with physicians and other healthcare professionals, etc.).

The OIG believes that the following are important components of compliance:

  1. Implementation of written policies, procedures and standards of conduct;
  2. Designation of a compliance officer and compliance committee;
  3. Conducting effective training and education;
  4. Development of effective lines of communication;
  5. Conducting internal monitoring and auditing;
  6. Enforcement of standards through well-publicized disciplinary guidelines; and
  7. Responding promptly to detected offenses and undertaking corrective action.

HTCs should consider whether their compliance programs include these features. For example, is there any open line of communication between all staff and the person in charge of compliance, without interruption from supervisors or other personnel, to enable reporting of any cases of fraud, abuse, or waste? Employees should not be concerned about retaliation for reporting concerns of non-compliance which may necessitate that they can report outside of the managerial chain. Additionally, is the HTC conducting training at regular intervals (likely at least for new employees and annually) to staff and its Board of Directors on potential areas of risk? Training and education demonstrate a proactive approach to compliance and may help avoid problems before they develop.

The Hemophilia Alliance teams stands ready to assist HTCs however possible and answer any questions that you may have regarding high-quality compliance programs.

Also in this Issue…

Notes from Joe
· Washington Update

Payer Update
· Connecting The Dots

Alliance Update
· Update on New Member Meeting

Team Alliance Contact Information

We work for you! Please don’t hesitate to contact any of us with any questions or concerns:

Name Email Phone
Jeff Blake jeff@hemoalliance.org 317-657-5913
Jennifer Borrillo, MSW, LCSW, MBA borrillo@hemoalliance.org 504-376-5282
Heidi Lane, PT, DPT, PCS heidi@hemoalliance.org 435-659-1230
Angela Blue, MBA angela@hemoalliance.org 651-308-3902
Karen Bowe-Hause karen@hemoalliance.org 717-571-0266
Jazzmine Brown, MBA, MSW, LCSW jazzmine@hemoalliance.org 770-570-2649
Ashley Castello, MEd ashley@hemoalliance.org 225-266-5062
Zack Duffy zack@hemoalliance.org 503-804-2581
Michael B. Glomb MGlomb@ftlf.com 202-466-8960
Johanna Gray, MPA jgray@artemispolicygroup.com 703-304-8111
Kiet Huynh kiet@hemoalliance.org 917-362-1382
Elizabeth Karan elizabeth@karanlegalgroup.com 612-202-3240
Kollet Koulianos, MBA kollet@hemoalliance.org 309-397-8431
Roland P. Lamy, Jr. roland@hemoalliance.org 603-491-0853
Julie Lichterman julie@hemoalliance.org 941-779-5971
Dr. George L. Oestreich, Pharm.D., MPA george@gloetal.com 573-230-7075
Theresa Parker theresa@hemoalliance.org 727-688-2568
Mark Plencner mark@hemoalliance.org 701-318-2910
Ellen Riker eriker@artemispolicygroup.com 202-257-6670